ANATOLIAN JOURNAL OF CARDIOLOGY, vol.25, no.11, pp.789-795, 2021 (SCI-Expanded)
Objective: To evaluate the prognostic value of preprocedural CHA(2)DS(2)-VASc [congestive heart failure, hypertension, age >= 75 years (doubled), diabetes mellitus, previous stroke or transient ischemic attack (TIA) (doubled), vascular disease, age 65-74 years, female gender] score in predicting high SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score and in-hospital mortality for non-atrial fibrillation (AF) patients presenting with non-ST elevation myocardial infarction (NSTEMI). The CHA(2)DS(2)-VASc score used to determine thromboembolic risks in AF was recently reported to predict major adverse clinical outcomes in patients with the acute coronary syndrome, irrespective of AF.